Helena Pópulo

Summary

Affiliation: Institute of Molecular Pathology and Immunology
Country: Portugal

Publications

  1. pmc The mTOR signalling pathway in human cancer
    Helena Pópulo
    Institute of Molecular Pathology and Immunology of University of Porto IPATIMUP, University of Porto, 4200 465, Porto, Portugal E Mails H P J M L
    Int J Mol Sci 13:1886-918. 2012
  2. doi request reprint Telomerase promoter mutations in cancer: an emerging molecular biomarker?
    João Vinagre
    Institute of Molecular Pathology and Immunology of University of Porto IPATIMUP, 4200 465, Porto, Portugal
    Virchows Arch 465:119-33. 2014
  3. pmc Mitochondrial dynamics protein drp1 is overexpressed in oncocytic thyroid tumors and regulates cancer cell migration
    André Ferreira-da-Silva
    Institute of Molecular Pathology and Immunology of the University of Porto IPATIMUP, Porto, Portugal Department of Pathology, Medical Faculty of University of Porto, Porto, Portugal
    PLoS ONE 10:e0122308. 2015
  4. doi request reprint Analysis of GNAQ mutations, proliferation and MAPK pathway activation in uveal melanomas
    Helena Pópulo
    Institute of Molecular Pathology and Immunology, University of Porto, Porto, Portugal
    Br J Ophthalmol 95:715-9. 2011

Collaborators

  • Valdemar Máximo
  • Paula Soares
  • André Ferreira-da-Silva
  • Manuel Sobrinho-Simoes
  • João Vinagre
  • Cristina Valacca
  • Luca Scorrano
  • Elisabete Rios
  • Silvia Campello
  • Telmo Catarino
  • Jorge Lima
  • Vasco Pinto
  • Miguel Melo
  • Jose Manuel Lopes
  • Ricardo Celestino
  • Marta Reis
  • Paula Boaventura

Detail Information

Publications4

  1. pmc The mTOR signalling pathway in human cancer
    Helena Pópulo
    Institute of Molecular Pathology and Immunology of University of Porto IPATIMUP, University of Porto, 4200 465, Porto, Portugal E Mails H P J M L
    Int J Mol Sci 13:1886-918. 2012
    ..In this review, we aim to survey relevant research, the molecular mechanisms of signalling, including upstream activation and downstream effectors, and the role of mTOR in cancer, mainly in melanoma...
  2. doi request reprint Telomerase promoter mutations in cancer: an emerging molecular biomarker?
    João Vinagre
    Institute of Molecular Pathology and Immunology of University of Porto IPATIMUP, 4200 465, Porto, Portugal
    Virchows Arch 465:119-33. 2014
    ....
  3. pmc Mitochondrial dynamics protein drp1 is overexpressed in oncocytic thyroid tumors and regulates cancer cell migration
    André Ferreira-da-Silva
    Institute of Molecular Pathology and Immunology of the University of Porto IPATIMUP, Porto, Portugal Department of Pathology, Medical Faculty of University of Porto, Porto, Portugal
    PLoS ONE 10:e0122308. 2015
    ..In this study we show that unbalanced mitochondrial dynamics characterize the malignant features of thyroid oncocytic cell tumors, and participate in the acquisition of the migrating phenotype. ..
  4. doi request reprint Analysis of GNAQ mutations, proliferation and MAPK pathway activation in uveal melanomas
    Helena Pópulo
    Institute of Molecular Pathology and Immunology, University of Porto, Porto, Portugal
    Br J Ophthalmol 95:715-9. 2011
    ..To study the GNAQ mutational status in a series of uveal melanomas and evaluate possible associations with mitogen-activated protein kinase (MAPK) pathway protein expression and tumour proliferation markers...